Cookies on this website
We use cookies to ensure that we give you the best experience on our website. If you click 'Continue' we'll assume that you are happy to receive all cookies and you won't see this message again. Click 'Find out more' for information on how to change your cookie settings.

The therapeutic options for patients with advanced non-small-cell lung cancer (NSCLC) are palliative. Therefore, the quality of life in oncology is considered as an endpoint in clinical trials, and several scales have been accepted for its measurement in parallel with other clinical determinations. However, its use in clinical practice is hindered by various obstacles that need to be overcome. In this article we examine the concept of the quality of life in patients with NSCLC, as well as giving an evaluation and interpretation of the results of various clinical trials. We describe the new technological methods used in daily clinical practice to measure the quality of life.

Original publication

DOI

10.3816/clc.2009.n.010

Type

Journal article

Journal

Clinical lung cancer

Publication Date

03/2009

Volume

10

Pages

83 - 90

Addresses

Servicio de Oncología Médica, Hospital General Universitario, Valencia, Spain. camps_car@gva.es

Keywords

Humans, Carcinoma, Non-Small-Cell Lung, Lung Neoplasms, Palliative Care, Quality of Life